John Hertia
CIK 1616003 · View on SEC EDGAR ↗
First SEC filing: Sept. 12, 2014 · Latest: Sept. 12, 2014
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 12, 2019 | BIO | S | 797 | $328.25 | $261,615 | 18,769 Direct | -4.07% | Disposed | 11.1% (price as of 2026-08-20) |
| Sept. 12, 2019 | BIO | S | 41 | $329.00 | $13,489 | 18,728 Direct | -0.22% | Disposed | 10.8% (price as of 2026-08-20) |
| Nov. 25, 2014 | BIO | S | 6,000 | $119.39 | $716,340 | 9,475 Direct | -38.77% | Disposed | 205.4% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Sept. 12, 2019 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (600) | $119.54 | Sept. 10, 2024 | 600 | Disposed |
| Sept. 12, 2019 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (600) | $139.56 | Sept. 11, 2025 | 600 | Disposed |
| Sept. 11, 2019 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (600) | — | — | 600 | Disposed |
| Nov. 25, 2014 | BIO | Incentive stock Option (right to buy) | Bio-Rad A Common Stock (1,696) | $62.47 | April 3, 2016 | 1,696 | Disposed |
| Nov. 25, 2014 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (4,304) | $62.47 | April 3, 2016 | 4,304 | Disposed |
| Nov. 4, 2014 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (600) | — | — | 600 | Disposed |
| Sept. 12, 2014 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (600) | — | — | 600 | Disposed |
| Sept. 11, 2014 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (600) | — | — | 600 | Disposed |
| Sept. 11, 2014 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (700) | — | — | 700 | Disposed |
| Sept. 10, 2014 | BIO | Restricted Stock Units | Bio-Rad A Common Stock (3,000) | — | — | 3,000 | Acquired |
| Sept. 10, 2014 | BIO | Non-Qualified Stock Option (right to buy) | Bio-Rad A Common Stock (3,000) | $119.54 | Sept. 10, 2024 | 3,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 8 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 12, 2014 | BIO | Bio-Rad A Common Stock | 7,899 | Direct |
| Sept. 12, 2014 | BIO | Bio-Rad A Common Stock | 252 | Indirect |
| Sept. 12, 2014 | BIO | Incentive Stock Option (right to buy)→ Bio-Rad A Common Stock (1,696) | 1,696 | Direct |
| Sept. 12, 2014 | BIO | Non-Qualified Stock Option (right to buy)→ Bio-Rad A Common Stock (4,304) | 4,304 | Direct |
| Sept. 12, 2014 | BIO | Restricted Stock Units→ Bio-Rad A Common Stock (1,200) | 1,200 | Direct |
| Sept. 12, 2014 | BIO | Restricted Stock Units→ Bio-Rad A Common Stock (1,800) | 1,800 | Direct |
| Sept. 12, 2014 | BIO | Restricted Stock Units→ Bio-Rad A Common Stock (2,400) | 2,400 | Direct |
| Sept. 12, 2014 | BIO | Restricted Stock Units→ Bio-Rad A Common Stock (3,500) | 3,500 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2016 | $479,556 | — | — | — | — | — | — | $1,273,930 |
| 2015 | $465,253 | — | — | — | $317,244 | — | $17,838 | $1,324,163 |
| 2014 | $432,646 | — | — | — | — | — | — | $1,146,431 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.